Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Santen Pharmaceutical CoTSE:4536 +3.04%78 Dividend Yield % is 1.97% as of Aug. 09, 2026, which is 6% above its 10-year median of 1.86. GuruFocus rates TSE:4536 with a GF Score™ of 78/100 and a GF Value™ of 円1,706.18 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 513 Drug Manufacturers companies, Santen Pharmaceutical Co ranks better than 50.1% on this metric.
As of today (2026-08-09), the Trailing Annual Dividend Yield of Santen Pharmaceutical Co is 1.97%.
The historical rank and industry rank for Santen Pharmaceutical Co's Dividend Yield % or its related term are showing as below:
TSE:4536'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.21 Med: 1.86 Max: 3.33
Current: 1.97
During the past 13 years, the highest Dividend Yield of Santen Pharmaceutical Co was 3.33%. The lowest was 1.21%. And the median was 1.86%.
TSE:4536's Dividend Yield % is ranked better than 50.1% of 513
companies
in the Drug Manufacturers industry
Industry Median: 1.97
vs TSE:4536: 1.97
During the past 12 months, Santen Pharmaceutical Co's average Dividends Per Share Growth Rate was 5.60% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 5.60% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 4.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Santen Pharmaceutical Co was 17.00% per year. The lowest was 1.30% per year. And the median was 5.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Santen Pharmaceutical Co (TSE:4536) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4536 vs LLY, JNJ, ABBV: Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Santen Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Santen Pharmaceutical Co's Dividend Yield % falls into.
Santen Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Santen Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 19.000000
2026-03-30
2026-03-31
2026-06-24
Cash Dividend
semi-annually
JPY:JPY 1.000000
JPY 19.000000
2025-09-29
2025-09-30
2025-11-28
Cash Dividend
semi-annually
JPY:JPY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Santen Pharmaceutical Co (TSE:4536) has a Dividend Yield % of 1.97% as of Aug. 09, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Santen Pharmaceutical Co and its competitors. This is near median its historical median of 1.86. Over the past decade, Santen Pharmaceutical Co's Dividend Yield % has ranged from 1.21 to 3.33. According to the industry distribution chart, Santen Pharmaceutical Co ranks #256 out of 513 companies in the Drug Manufacturers industry, placing it in the top 49.9%.
Is Santen Pharmaceutical Co's Dividend Yield % too high?
Santen Pharmaceutical Co's current Dividend Yield % of 1.97% is near median its 10-year median of 1.86. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 3.33. The Drug Manufacturers industry median Dividend Yield % is 1.97. Santen Pharmaceutical Co's value of 1.97% is 0% at this industry median. Based on the distribution chart, Santen Pharmaceutical Co ranks #256 out of 513 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Santen Pharmaceutical Co has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Santen Pharmaceutical Co's Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Santen Pharmaceutical Co ranks #256 out of 513 companies for Dividend Yield %. This puts Santen Pharmaceutical Co in the upper half of its industry. The industry median Dividend Yield % is 1.97. Santen Pharmaceutical Co's value of 1.97% is 0% at this benchmark. Historically, Santen Pharmaceutical Co's own Dividend Yield % has ranged from 1.21 to 3.33 over the past decade. While the company's 10-year median is 1.86 vs. the industry median of 1.97, Santen Pharmaceutical Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.97, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Santen Pharmaceutical Co's current Dividend Yield % of 1.97% is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Santen Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Santen Pharmaceutical Co's current Dividend Yield % is 1.97%, which is near median its own 10-year median of 1.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santen Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Santen Pharmaceutical Co (TSE:4536) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,706.18, compared to a current price of 円1,933.00 — trading 13.3% above its estimated fair value. The current Dividend Yield % is 1.97%, which is near median its 10-year median of 1.86 and 0% at the Drug Manufacturers industry median of 1.97. Santen Pharmaceutical Co's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Santen Pharmaceutical Co (TSE:4536), the current Dividend Yield % is 1.97% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Santen Pharmaceutical Co (TSE:4536) Overvalued in 2026?
Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円1,933.00 is trading 13.3% above its estimated GF Value™ of 円1,706.18.
GuruFocus considers Santen Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for TSE:4536:
Dividend Yield %: 1.97% (near median its 10-year median of 1.86)
GF Value™: 円1,706.18 vs. price of 円1,933.00 (13.3% above fair value)
Industry Position: 0% at the Drug Manufacturers median (#256 of 513)
No single metric tells the full story. See the TSE:4536 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
78GF Score
Get the complete analysis for TSE:4536
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4536 has been successfully added to your 
